CAB-051

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCAB-051
Drug Alias Nameanti-HER-2 humanized antibodies (Biotecnol)anti-erbB2 humanized antibodies (Biotecnol)CAB-051CAB-052
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsAnticancer protein kinase inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotecnol Sa
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A